Meet PRC2: A new player in T-cell acute lymphoblastic leukemia.

Polycomb Repressive Complex 2 (PRC2) is a key epigenetic regulator involved in T-cell biology and leukemogenesis. While traditionally known for gene silencing via H3K27me3, recent studies reveal roles in T-cell differentiation, thymocyte maturation, and T-ALL pathogenesis. Here, we present, for the first time, an analysis of T-ALL samples with alterations in PRC1 and PRC2 subunits from the TARGET database. We examine the distribution of molecular alterations in patients with impaired PRC2 across different maturation stages and molecular subtypes, providing novel insights into PRC2's mechanistic involvement in disease progression.